Company's next-generation EMR platform, Nexia™ EMR, to
incorporate PEPID's electronic decision-support resources and the
Canadian Pharmacists Association's drug information
content
MARKHAM, ON,
May 9, 2013 /CNW/ - Nightingale
Informatix Corporation ("Nightingale" or the "Company") (TSX-V:
NGH), a provider of cloud-based electronic medical record (EMR)
software and related services, today announced that it has
partnered with PEPID, a multi-national provider of electronic
decision-support resources for healthcare professionals, to
incorporate its Canadian drug reference tools into Nightingale's
next-generation platform - Nexia™ EMR. As part of this agreement,
Nightingale has also established a partnership with the Canadian
Pharmacists Association ("CPhA"), which publishes Canada's trusted bilingual drug reference, the
Compendium of Pharmaceuticals and Specialties (CPS), to
incorporate their drug information into Nexia™ EMR.
As a result of these partnerships, Nexia™ EMR
will offer users real-time access to a comprehensive set of
clinical decision support tools for medication management.
Additionally, practitioners will have access to a trusted set of
evidence-based drug information in both English and French.
"With its intuitive functionality, cloud-based
access and seamless ability to integrate with third-party tools and
information, we believe Nexia™ EMR will be a disruptive force in
the North American EMR marketplace," said Sam Chebib, President & CEO of Nightingale.
"Partnering with these two leading organizations is an important
element in our strategy to develop a truly differentiated
next-generation EMR offering. Our more comprehensive Nexia™ EMR
platform can enhance patient care and safety, as well as bring
additional benefits to the healthcare provider in terms of process
and efficiency."
Through Nexia™ EMR, healthcare providers will
have access to PEPID's clinical decision-support tools that inform
them of potential drug interactions, duplicate therapy and
potential contraindications with laboratories, pregnancy and
medical conditions, at the point-of-care. In addition, the drug
monographs and patient handouts from the CPhA will enable
Nightingale's clients to stay current on the latest news on
medication, helping to ensure a high level of patient safety.
"I'm proud Nightingale has chosen PEPID as their
decision-support partner," said John
Wagner, PEPID president. "PEPID delivers comprehensive,
instantly accessible point-of-care reference materials so that
healthcare providers are able to offer faster, safer and more
effective care wherever they are - whether it's in a hospital, in
their clinic, on the road or in a disaster zone. Nightingale's
Nexia™ EMR clients can be confident that their prescribing
decisions have been checked against the most authoritative resource
available."
"It is clear that Nightingale is leading the
charge in Canada, when it comes to
integrating medication safety tools into an EMR solution," said Dr.
James de Gaspé Bonar, Senior Director, Digital Publishing Solutions
at CPhA. "The synergy between our organizations was apparent very
early on. Nightingale's team is committed to patient safety and is
eager to integrate industry-leading information sources, like ours,
into their application. We are looking forward to collaborating
with Nightingale on other initiatives as our relationship
evolves."
About Nightingale
Nightingale is one of the fastest growing health care service and
software companies in North
America and is recognized as an industry leader in Web-based
clinician and community based electronic medical records (EMR)
serving the needs of small primary care practices, multi-physician
outpatient clinics, and large scale regional health organizations
and networks. Nightingale's comprehensive service offering allows
customers to enhance patient care, increase revenue opportunities
and optimize operations. Nightingale is continuously innovating and
enhancing its services to meet the needs of its growing and diverse
customer base. Nightingale - Healthcare connected.
www.nightingalemd.ca
About PEPID LLC
PEPID utilizes mobile and online technology to deliver clinical
decision-support resources specific for healthcare professionals
including doctors, nurses, EMTs and students. PEPID content is
reviewed and contributed to by partners including the American
Academy of Emergency Medicine, the National Association of
Emergency Medical Services Educators, the Family Physician
Inquiries Network, the National Association of Clinical Nurse
Specialists, the Oncology Nursing Society, and the American Society
of Health-System Pharmacists to ensure content is of the highest
quality. Learn more about PEPID at www.pepid.com or
www.pepid.ca.
About the Canadian Pharmacists Association
The Canadian Pharmacists Association is the nonprofit organization
that advocates for pharmacists in Canada. CPhA stays on the cutting edge of
breaking news in health care and ensures that pharmacists are
included in discussions on the changing health care landscape. CPhA
publishes Canadian therapeutic and drug information in print,
online and mobile formats, making it accessible to health care
providers at point-of-care. Innovation, advocacy, education,
information and collaboration are some of the major areas the CPhA
focuses on to support pharmacists and advance the profession. CPhA
puts the tools pharmacists need in their daily practice in their
fingertips and develops innovative ways to help clinicians provide
optimal patient-centred care. Find out more at
www.pharmacists.ca.
Forward Looking Statement
This press release contains "forward-looking statements"
respecting the issuance and cancellation of securities of the
Company within the meaning of applicable Canadian securities
legislation. Generally, forward-looking statements can be
identified by the use of forward- looking terminology such as
"plans", "expects" or "does not expect", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or state that certain actions, events or results "may"
,"could", "would", "might", "occur" or "be achieved".
Forward-looking statements are subject to known and unknown risks,
uncertainties and other factors that may cause the actual results,
level of activity, performance or achievements of Nightingale to be
materially different from those expressed or implied by such
forward-looking statements, including but not limited to: risks
related to the speculative nature of the medical software industry,
which is affected by numerous factors beyond Nightingale's control;
the ability of Nightingale to successfully secure customer
contracts and the timing of securing such contracts; the ability of
Nightingale to complete and successfully integrate its acquisitions
on an accretive basis, Nightingale's access to debt and capital
facilities, including compliance with current debt arrangements;
the existence of present and possible future government regulation;
the significant competition that exists in the medical software
industry; the early stage of Nightingale's business, and risks
associated with early stage companies, including uncertainty of
revenues, markets and profitability and the need to raise
additional funding. All material assumptions used in making
forward-looking statements are based on management's knowledge of
current business conditions and expectations of future business
conditions and trends. Certain material factors or assumptions
applied by management in making forward-looking statements, include
without limitation, factors and assumptions regarding future trends
in healthcare spending, economic conditions affecting Nightingale
and North American economies; Nightingale's ability to continue to
fund its business, rates of customer defaults, relationships with,
and payments to lenders, as well as Nightingale's operating cost
structure.
Although Nightingale has attempted to
identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements, there may be other factors that cause results not to be
as anticipated, estimated or intended. There can be no assurance
that such statements will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking statements. Nightingale does not
undertake to update any forward-looking statements that are
incorporated by reference herein, except in accordance with
applicable securities laws. Further information on Nightingale
Informatix Corporation is available at www.sedar.com.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Nightingale Informatix Corporation